Updated on 9 July 2013
The report analyzed 640 leading market players are profiled 48 key companies that project improved market activities in the near future.
"The evolution of biochips has opened new vistas in the biological systems. In addition, all other sciences are integrated which cumulatively contribute for a big future of biochip industry. The broad ‘life science' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years," the report analysed.
Further, experts pointed out that DNA biochips and lab-on-chips have created revolution enabling the target validation. "Genome scan is very soon going to become an ultimate weapon for diagnosis. In no time all the information related to genes will be sequenced, annotated and completed along with the list of diseases which are susceptible. Day to day the researchers are also making an effort to develop medication to control the various diseases, by using biochip technology. As the applications of biochips are wide both in the research and clinical use, a wide potential market is expected," it explained.